- Home
- ACIU vs SLNH Comparison
ACIU vs SLNH Comparison
Compare ACIU & SLNH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACIU | SLNH |
|---|---|---|
| Founded | 2003 | 1961 |
| Country | Switzerland | United States |
| Employees | N/A | 52 |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 244.3M | 263.4M |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | ACIU | SLNH |
|---|---|---|
| Price | $2.51 | $1.37 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $10.00 | $5.00 |
| AVG Volume (30 Days) | 298.1K | ★ 18.4M |
| Earning Date | 05-12-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $706.75 | $55.83 |
| Revenue Next Year | $321.13 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.65 | $0.42 |
| 52 Week High | $4.00 | $5.14 |
Technical Indicators
Market Signals| Indicator | ACIU | SLNH |
|---|---|---|
| Relative Strength Index (RSI) | 51.75 | 42.11 |
| Support Level | N/A | $1.19 |
| Resistance Level | $3.20 | $1.78 |
| Average True Range (ATR) | 0.12 | 0.20 |
| MACD | 0.04 | -0.03 |
| Stochastic Oscillator | 86.54 | 21.54 |
Price Performance
Historical ComparisonAbout ACIU AC Immune SA
AC Immune SA is a clinical stage biopharmaceutical company advancing a portfolio of programs strategically focused on pioneering Precision Medicine for neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company has one segment. The company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About SLNH Soluna Holdings Inc.
Soluna Holdings Inc is a U.S.-based company engaged in the development and operation of data centers powered by renewable energy. The company utilizes excess or curtailed energy from renewable sources to support high-performance computing applications, including cryptocurrency mining, artificial intelligence, and machine learning. Its business model focuses on converting underutilized renewable energy into computing resources through co-located data center infrastructure.